Hosa Diganta: MIMS and ManMed Dynamics begin joint research on AI to detect cancer during surgery

On 2 December 2025 the Kannada daily Hosa Diganta (page 7) reported, under the headline “ಕ್ಯಾನ್ಸರ್ ಪತ್ತೆಗೆ ಎಐ ತಂತ್ರಜ್ಞಾನ ಬಳಕೆ” (“AI technology for cancer detection”), that Mandya Institute of Medical Sciences (MIMS) and the med-tech start-up ManMed Dynamics have jointly begun a two-year research programme to identify, in real time, cancer tissue that can remain at the edges of a surgical resection.

According to the report, the study, Smart Surgical Margins, combines near-infrared (NIR) fluorescence imaging with indocyanine green (ICG), machine-vision optics and a learning-based AI model on one low-cost platform for examining excised tissue. The report adds that the study is registered with the Clinical Trials Registry – India (CTRI) and approved by the MIMS Institutional Ethics Committee, that its first phase is supported by an intramural grant from the MIMS Multidisciplinary Research Unit, and that the system is meant to be affordable for government and district hospitals.

Quoted in the report

• Dr P. Narasimhaswamy, Director, MIMS: the project brings MIMS’s clinical standards and rigorous engineering together on one platform — an important milestone for cancer surgery.
• Dr N. Lingaraju, chief investigator, MIMS: starting at the laboratory level keeps patients safe, and gives accurate, pathology-confirmed evidence before any move to the operating theatre.
• Ing. Vishwas Gowda P N, technical lead investigator: with every confirmed case the platform’s AI model learns, so that sensitivity and specificity improve step by step over the two years.

The study is at the research stage and has not reported results. Read more about the work on the OncoVision page.

Source: Hosa Diganta, Mandya, 2 December 2025, page 7 (clipping above). Summary and translation from Kannada by ManMed Dynamics.